Stay updated on ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.

Latest updates to the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe NIH banner announcing website updates and a transition in terminology was removed from the page.SummaryDifference1%

- Check17 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error rather than study details.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It appears above the study page’s 403 error.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study record page displays a 403 Forbidden error instead of study information.SummaryDifference0.2%

Stay in the know with updates to ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.